Taking the Long View: Medical Comorbidities that May Shift Treatment Decision-MakingPremiere Date: Tuesday, June 22, 2021
This activity offers CE credit for:%>
- Physicians (CME)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Wednesday, June 22, 2022
Note: Credit Is No Longer Available
|Princy N. Kumar, MD, FIDSA, MACP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Georgetown University School of Medicine
Hepatitis B virus (HBV) poses a significant burden, as it is associated with an increased risk of morbidity and mortality in conjunction with a reduced quality of life (QoL). It is imperative that clinicians take the long view when considering medical comorbidities that may shift treatment decision-making, including recognizing that patients with chronic hepatitis B (CHB) are at-risk for bone loss independent of their antiviral treatment and aligning treatment initiation and switching decisions to AASLD guideline recommendations in the presence of renal impairment and/or bone loss.
This CME Outfitters BriefCase introduces Khadi, a 58-year-old woman who recently immigrated to the United States from Ghana and presents to her primary care provider for a new patient examination. This case will show how to optimize efficacy and safety profiles of current agents when initiating or switching treatment in patients with HBV.
At the end of this CE activity, participants should be able to:
- Optimize efficacy and safety profiles of current agents when initiating or switching treatment in patients with HBV.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Describe efficacy and safety profiles of current agents for treatment in patients with HBV.
Supported by an educational grant from Gilead Sciences, Inc.
Primary care physicians, PAs, nurse practitioners, nurses, and pharmacists
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.5 contact hours (0.05 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
Note to PAs: PAs may claim a maximum of 0.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Kumar reports that she receives grants from Gilead Sciences, Inc.; GlaxoSmithKline; and Merck & Co, Inc. She is a consultant for Amgen Inc.; GlaxoSmithKline; and Merck & Co., Inc. She is a stock shareholder (directly purchased) of Gilead Sciences, Inc.; Johnson & Johnson; Merck & Co., Inc.; and Pfizer Inc.
Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).